Increased Circulating Levels of Tumor Necrosis Factor-like Cytokine 1A and Decoy Receptor 3 Correlate with SYNTAX Score in Patients Undergoing Coronary Surgery

Overview

Journal J Int Med Res

Publisher Sage Publications

Specialty General Medicine

Date 2018 Sep 15

PMID 30213220

Citations 4

Authors

Xin-Ya Li

Hai-Tao Hou

Huan-Xin Chen

Zheng-Qing Wang

Guo-Wei He

Affiliations

Soon will be listed here.

Abstract

Objective: Chronic inflammation of the arteries is a critical mechanism responsible for coronary atherosclerosis. We aimed to determine if tumor necrosis factor (TNF)-like cytokine 1A (TL1A) and decoy receptor 3 (DcR3) were involved in promoting atherosclerosis.

Methods: We compared plasma levels of TL1A and DcR3 in patients with coronary artery disease (CAD) undergoing coronary artery bypass grafting (n=40) and patients without CAD group (n=37, normal coronary artery angiogram) by enzyme-linked immunosorbent assay. We also analyzed the correlation between CAD and SYNTAX scores.

Results: Plasma levels of TL1A and DcR3 were significantly higher in the CAD compared with the no-CAD group. Multivariate analysis showed that TL1A and DcR3 were significantly correlated with the presence of CAD, and receiver operating characteristic curve analysis indicated that both TL1A and DcR3 showed high sensitivity and specificity for diagnosing CAD. Furthermore, TL1A was positively and significantly correlated with SYNTAX score in CAD patients.

Conclusions: CAD patients requiring coronary artery bypass grafting have high circulating levels of both TL1A and DcR3, which may thus be useful biomarkers for diagnosing severe CAD. Furthermore, plasma levels of TL1A correlate with SYNTAX score, supporting its potential use as an indicator of the severity of CAD.

Citing Articles

Research Progress of DcR3 in the Diagnosis and Treatment of Sepsis.

Su J, Tong Z, Wu S, Zhou F, Chen Q Int J Mol Sci. 2023; 24(16).

PMID: 37629097 PMC: 10454171. DOI: 10.3390/ijms241612916.

Soluble Tumor Necrosis Factor Receptor 1 is Associated With Cardiovascular Risk in Persons With Coronary Artery Calcium Score of Zero.

Dong T, Bevan G, Zidar D, Achirica M, Nasir K, Rashid I Pathog Immun. 2022; 6(2):135-148.

PMID: 34988343 PMC: 8714175. DOI: 10.20411/pai.v6i2.477.

The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease.

Qi Y, Xu J, Lin Z, Tao Y, Zheng F, Wang Y J Inflamm Res. 2021; 14:6043-6053.

PMID: 34824540 PMC: 8610753. DOI: 10.2147/JIR.S338763.

Decoy Technology as a Promising Therapeutic Tool for Atherosclerosis.

Mahjoubin-Tehran M, Teng Y, Jalili A, Aghaee-Bakhtiari S, Markin A, Sahebkar A Int J Mol Sci. 2021; 22(9).

PMID: 33922585 PMC: 8122884. DOI: 10.3390/ijms22094420.

References

McLaren J, Calder C, McSharry B, Sexton K, Salter R, Singh N . The TNF-like protein 1A-death receptor 3 pathway promotes macrophage foam cell formation in vitro. J Immunol. 2010; 184(10):5827-34. PMC: 2874519. DOI: 10.4049/jimmunol.0903782. View

Bamias G, Kaltsa G, Siakavellas S, Gizis M, Margantinis G, Zampeli E . Differential expression of the TL1A/DcR3 system of TNF/TNFR-like proteins in large vs. small intestinal Crohn's disease. Dig Liver Dis. 2011; 44(1):30-6. DOI: 10.1016/j.dld.2011.09.002. View

Otsuki T, Tomokuni A, Sakaguchi H, Aikoh T, Matsuki T, Isozaki Y . Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients. Clin Exp Immunol. 2000; 119(2):323-7. PMC: 1905509. DOI: 10.1046/j.1365-2249.2000.01132.x. View

Chang T, Hsu C, Huang P, Chiang C, Leu H, Huang C . Usefulness of Circulating Decoy Receptor 3 in Predicting Coronary Artery Disease Severity and Future Major Adverse Cardiovascular Events in Patients With Multivessel Coronary Artery Disease. Am J Cardiol. 2015; 116(7):1028-33. DOI: 10.1016/j.amjcard.2015.06.041. View

Zhan C, Patskovsky Y, Yan Q, Li Z, Ramagopal U, Cheng H . Decoy strategies: the structure of TL1A:DcR3 complex. Structure. 2011; 19(2):162-71. PMC: 3065972. DOI: 10.1016/j.str.2010.12.004. View

Funke B, Autschbach F, Kim S, Lasitschka F, Strauch U, Rogler G . Functional characterisation of decoy receptor 3 in Crohn's disease. Gut. 2008; 58(4):483-91. DOI: 10.1136/gut.2008.148908. View

Kang Y, Kim W, Bae H, Kim D, Park Y, Park J . Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis. Cytokine. 2005; 29(5):229-35. DOI: 10.1016/j.cyto.2004.12.001. View

Bamias G, Kaltsa G, Siakavellas S, Papaxoinis K, Zampeli E, Michopoulos S . High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis. Clin Immunol. 2010; 137(2):242-9. DOI: 10.1016/j.clim.2010.07.001. View

Zhang X, Hou H, Wang J, Liu X, Yang Q, He G . Plasma Proteomic Study in Pulmonary Arterial Hypertension Associated with Congenital Heart Diseases. Sci Rep. 2016; 6:36541. PMC: 5122864. DOI: 10.1038/srep36541. View

10.

Chen C, Yang K, Chen M, Chen H, Lin M, Lee Y . Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2009; 180(8):751-60. DOI: 10.1164/rccm.200902-0222OC. View

11.

Morice M, Serruys P, Kappetein A, Feldman T, Stahle E, Colombo A . Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial. Circulation. 2014; 129(23):2388-94. DOI: 10.1161/CIRCULATIONAHA.113.006689. View

12.

Migone T, Zhang J, Luo X, Zhuang L, Chen C, Hu B . TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity. 2002; 16(3):479-92. DOI: 10.1016/s1074-7613(02)00283-2. View

13.

Hansson L, Hedner T, Himmelmann A . The 1999 WHO-ISH Guidelines for the Management of Hypertension--new targets, new treatment and a comprehensive approach to total cardiovascular risk reduction. Blood Press Suppl. 1999; 1:3-5. View

14.

Garg S, Sarno G, Girasis C, Vranckx P, de Vries T, Swart M . A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials. JACC Cardiovasc Interv. 2011; 4(6):645-53. DOI: 10.1016/j.jcin.2011.02.018. View

15.

Kim S, Lee W, Kwon B, Oh G, Choi Y, Park J . Tumor necrosis factor receptor superfamily 12 may destabilize atherosclerotic plaques by inducing matrix metalloproteinases. Jpn Circ J. 2001; 65(2):136-8. DOI: 10.1253/jcj.65.136. View

16.

Stamatelopoulos K, Georgiou S, Kanakakis I, Papamichael C, Oikonomidis N, Mantzou A . Circulating levels of TNF-like cytokine 1A correlate with reflected waves and atherosclerosis extent and may predict cardiac death in patients with stable coronary artery disease. Cytokine. 2015; 72(1):102-4. DOI: 10.1016/j.cyto.2014.12.016. View

17.

Bamias G, Evangelou K, Vergou T, Tsimaratou K, Kaltsa G, Antoniou C . Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions. Exp Dermatol. 2011; 20(9):725-31. DOI: 10.1111/j.1600-0625.2011.01304.x. View

18.

Gao G, Xuan C, Yang Q, Liu X, Liu Z, He G . Identification of altered plasma proteins by proteomic study in valvular heart diseases and the potential clinical significance. PLoS One. 2013; 8(8):e72111. PMC: 3754973. DOI: 10.1371/journal.pone.0072111. View

19.

Yadav M, Palmerini T, Caixeta A, Madhavan M, Sanidas E, Kirtane A . Prediction of coronary risk by SYNTAX and derived scores: synergy between percutaneous coronary intervention with taxus and cardiac surgery. J Am Coll Cardiol. 2013; 62(14):1219-1230. DOI: 10.1016/j.jacc.2013.06.047. View

20.

Bamias G, Stamatelopoulos K, Zampeli E, Protogerou A, Sigala F, Papamichael C . Circulating levels of TNF-like cytokine 1A correlate with the progression of atheromatous lesions in patients with rheumatoid arthritis. Clin Immunol. 2013; 147(2):144-50. DOI: 10.1016/j.clim.2013.03.002. View